Johannes Drach

12.2k total citations
177 papers, 7.4k citations indexed

About

Johannes Drach is a scholar working on Hematology, Molecular Biology and Oncology. According to data from OpenAlex, Johannes Drach has authored 177 papers receiving a total of 7.4k indexed citations (citations by other indexed papers that have themselves been cited), including 99 papers in Hematology, 73 papers in Molecular Biology and 66 papers in Oncology. Recurrent topics in Johannes Drach's work include Multiple Myeloma Research and Treatments (81 papers), Lymphoma Diagnosis and Treatment (48 papers) and Chronic Lymphocytic Leukemia Research (29 papers). Johannes Drach is often cited by papers focused on Multiple Myeloma Research and Treatments (81 papers), Lymphoma Diagnosis and Treatment (48 papers) and Chronic Lymphocytic Leukemia Research (29 papers). Johannes Drach collaborates with scholars based in Austria, United States and Czechia. Johannes Drach's co-authors include H. Huber, H. Kaufmann, Niklas Zojer, Michael Andreeff, Christoph Zielinski, Markus Raderer, Doris Drach, Andreas Chott, Heinz Ludwig and Heinz Gisslinger and has published in prestigious journals such as New England Journal of Medicine, The Journal of Experimental Medicine and Journal of Clinical Oncology.

In The Last Decade

Johannes Drach

174 papers receiving 7.2k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Johannes Drach 3.4k 3.2k 3.2k 1.7k 1.4k 177 7.4k
Andrew R. Belch 3.9k 1.1× 4.1k 1.3× 4.4k 1.4× 1.6k 1.0× 1.3k 1.0× 218 8.9k
David P. Schenkein 3.9k 1.2× 3.7k 1.1× 2.9k 0.9× 1.1k 0.7× 1.3k 0.9× 115 7.4k
Hans Erik Johnsen 2.1k 0.6× 2.6k 0.8× 2.3k 0.7× 1.5k 0.9× 1.2k 0.8× 261 7.1k
Jerry A. Katzmann 5.1k 1.5× 5.4k 1.7× 2.6k 0.8× 1.4k 0.8× 2.6k 1.8× 171 10.6k
David A. Rizzieri 3.0k 0.9× 4.3k 1.3× 2.5k 0.8× 916 0.5× 1.6k 1.1× 309 8.1k
Gérald Marit 3.3k 1.0× 5.9k 1.8× 3.3k 1.0× 1.8k 1.0× 2.2k 1.6× 193 8.6k
Joseph O. Moore 1.8k 0.5× 3.3k 1.0× 1.9k 0.6× 997 0.6× 1.5k 1.1× 148 6.6k
Pellegrino Musto 4.3k 1.3× 5.6k 1.7× 3.5k 1.1× 1.6k 0.9× 2.4k 1.8× 386 9.7k
Ingemar Turesson 4.0k 1.2× 6.2k 1.9× 3.5k 1.1× 860 0.5× 1.8k 1.3× 148 8.3k
Norbert Ifrah 3.9k 1.1× 7.3k 2.2× 3.5k 1.1× 1.2k 0.7× 1.7k 1.2× 231 11.4k

Countries citing papers authored by Johannes Drach

Since Specialization
Citations

This map shows the geographic impact of Johannes Drach's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Johannes Drach with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Johannes Drach more than expected).

Fields of papers citing papers by Johannes Drach

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Johannes Drach. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Johannes Drach. The network helps show where Johannes Drach may publish in the future.

Co-authorship network of co-authors of Johannes Drach

This figure shows the co-authorship network connecting the top 25 collaborators of Johannes Drach. A scholar is included among the top collaborators of Johannes Drach based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Johannes Drach. Johannes Drach is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Atamaniuk, Johanna, Andreas Gleiß, Edit Porpaczy, et al.. (2012). Overexpression of G protein‐coupled receptor 5D in the bone marrow is associated with poor prognosis in patients with multiple myeloma. European Journal of Clinical Investigation. 42(9). 953–960. 101 indexed citations
2.
Ludwig, Heinz, Roman Hájek, Elena Tóthová, et al.. (2008). Thalidomide-dexamethasone compared with melphalan-prednisolone in elderly patients with multiple myeloma. Blood. 113(15). 3435–3442. 148 indexed citations
3.
Heller, Gerwin, Wolfgang M. Schmidt, Barbara Ziegler, et al.. (2008). Genome-Wide Transcriptional Response to 5-Aza-2′-Deoxycytidine and Trichostatin A in Multiple Myeloma Cells. Cancer Research. 68(1). 44–54. 132 indexed citations
4.
Drach, Johannes, Sonja Seidl, & H. Kaufmann. (2005). Treatment of mantle cell lymphoma: targeting the microenvironment. Expert Review of Anticancer Therapy. 5(3). 477–485. 8 indexed citations
5.
Wöhrer, Stefan, Andreas Chott, Johannes Drach, et al.. (2004). Chemotherapy with cyclophosphamide, doxorubicin, etoposide, vincristine and prednisone (CHOEP) is not effective in patients with enteropathy-type intestinal T-cell lymphoma. Annals of Oncology. 15(11). 1680–1683. 37 indexed citations
6.
Wöhrer, Stefan, Andreas Püspök, Johannes Drach, et al.. (2004). Rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone (R-CHOP) for treatment of early-stage gastric diffuse large B-cell lymphoma. Annals of Oncology. 15(7). 1086–1090. 38 indexed citations
7.
Wöhrer, Stefan, Johannes Drach, Michael Hejna, et al.. (2003). Treatment of extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma) with mitoxantrone, chlorambucil and prednisone (MCP). Annals of Oncology. 14(12). 1758–1761. 46 indexed citations
8.
Kaufmann, H., J Ackermann, Hildegard Greinix, et al.. (2003). Beneficial effect of high-dose chemotherapy in multiple myeloma patients with unfavorable prognostic features. Annals of Oncology. 14(11). 1667–1672. 2 indexed citations
9.
Raderer, Markus, Andreas Chott, Johannes Drach, et al.. (2002). Chemotherapy for management of localised high-grade gastric B-cell lymphoma: how much is necessary?. Annals of Oncology. 13(7). 1094–1098. 46 indexed citations
10.
Zojer, Niklas, J. C. Schuster, Jutta Ackermann, et al.. (2002). Chromosomal aberrations are shared by malignant plasma cells and a small fraction of circulating CD19+ cells in patients with myeloma and monoclonal gammopathy of undetermined significance. British Journal of Haematology. 117(4). 852–859. 21 indexed citations
11.
Kaufmann, H., et al.. (2001). Advances in the biology and therapeutic management of multiple myeloma. Annals of Hematology. 80(8). 445–451. 13 indexed citations
12.
Worel, Nina, Hildegard Greinix, J Ackermann, et al.. (2001). Deletion of chromosome 13q14 detected by fluorescence in situ hybridization has prognostic impact on survival after high-dose therapy in patients with multiple myeloma. Annals of Hematology. 80(6). 345–348. 23 indexed citations
13.
Kaufmann, H., J Ackermann, Niklas Zojer, et al.. (2001). Absence of clonal chromosomal relationship between concomitant B-CLL and multiple myeloma - a report on two cases. Annals of Hematology. 80(8). 474–478. 28 indexed citations
14.
Fiegl, Michael, H. Kaufmann, Helene Wiener, et al.. (2000). Malignant cell detection by fluorescence in situ hybridization (FISH) in effusions from patients with carcinoma. Human Pathology. 31(4). 448–455. 25 indexed citations
15.
Filipits, Martin, Johannes Drach, Gudrun Pohl, et al.. (1999). Expression of the lung resistance protein predicts poor outcome in patients with multiple myeloma.. PubMed. 5(9). 2426–30. 39 indexed citations
16.
Engel, Heike, Johannes Drach, Afsaneh Keyhani, et al.. (1999). Quantitation of minimal residual disease in acute myelogenous leukemia and myelodysplastic syndromes in complete remission by molecular cytogenetics of progenitor cells. Leukemia. 13(4). 568–577. 25 indexed citations
17.
18.
Schwarzmeier, Josef D., Sabine Walchshofer, Niklas Zojer, et al.. (1998). A case of bone marrow mastocytosis associated with multiple myeloma. Annals of Hematology. 76(3-4). 167–174. 27 indexed citations
19.
Chiba, Peter, Gerhard F. Ecker, Diethart Schmid, et al.. (1996). Structural requirements for activity of propafenone-type modulators in P-glycoprotein-mediated multidrug resistance.. Molecular Pharmacology. 49(6). 1122–1130. 79 indexed citations
20.
Andreeff, Michael, Saili Zhao, Doris Drach, et al.. (1993). Expression of multidrug resistance (mdr-1) and p53 genes in hematologic cell systems: Implications for biology and gene therapy. 45(2). 131–138. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Andrew R. Belch Breakdown of academic impact, for papers by David P. Schenkein Breakdown of academic impact, for papers by Hans Erik Johnsen Breakdown of academic impact, for papers by Jerry A. Katzmann Breakdown of academic impact, for papers by David A. Rizzieri Breakdown of academic impact, for papers by Gérald Marit Breakdown of academic impact, for papers by Joseph O. Moore Breakdown of academic impact, for papers by Pellegrino Musto Breakdown of academic impact, for papers by Ingemar Turesson Breakdown of academic impact, for papers by Norbert Ifrah
Rankless by CCL
2026